Changes in CD40 ligand have also been tested in two studies, with only one 8-week RCT of twice-per-week fasting in 39 adults with metabolic syndrome, demonstrating a meaningful reduction in CD40 ligand vs. control after 8 weeks [92]. This evidence concerns the gene CD40LG and metabolic syndrome.